Arteris (NASDAQ:AIP) Major Shareholder Bayview Legacy, Llc Sells 70,000 Shares

Arteris, Inc. (NASDAQ:AIP) major shareholder Bayview Legacy, Llc sold 70,000 shares of the business’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $31.20, for a total value of $2,184,000.00. Following the completion of the transaction, the insider owned 9,049,071 shares of the company’s stock, valued at $282,331,015.20. This trade represents a 0.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Bayview Legacy, Llc also recently made the following trade(s):

• On Wednesday, April 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The shares were sold at an average price of $19.04, for a total value of $1,332,800.00.
• On Tuesday, March 10th, Bayview Legacy, Llc sold 9,000 shares of Arteris stock. The shares were sold at an average price of $14.66, for a total value of $131,940.00.
• On Monday, March 9th, Bayview Legacy, Llc sold 41,000 shares of Arteris stock. The shares were sold at an average price of $14.21, for a total value of $582,610.00.

Arteris Stock Performance

Shares of AIP opened at $32.43 on Wednesday. The stock has a fifty day moving average of $20.37 and a two-hundred day moving average of $17.15. The company has a market capitalization of $1.49 billion, a PE ratio of -39.55 and a beta of 1.93. Arteris, Inc. has a fifty-two week low of $6.88 and a fifty-two week high of $33.46.

Arteris (NASDAQ:AIP) last issued its quarterly earnings results on Thursday, February 12th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.03. The business had revenue of $20.14 million during the quarter, compared to analyst estimates of $18.55 million. As a group, equities research analysts forecast that Arteris, Inc. will post -0.68 earnings per share for the current fiscal year.

Trending Headlines about Arteris

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris posted a smaller-than-expected Q1 loss of $0.03 per share, beating the consensus loss estimate of $0.08 and improving from a $0.09 loss a year ago. Article Title
• Positive Sentiment: Revenue came in at $22.94 million, ahead of the $21.03 million estimate, showing stronger-than-expected demand and execution. Article Title
• Positive Sentiment: Management raised second-quarter and full-year revenue guidance, with Q2 sales expected at $23.0 million-$24.0 million and FY2026 revenue projected at $91.0 million-$95.0 million, both at or above analyst expectations. Article Title
• Neutral Sentiment: The company also released its earnings call transcript and investor materials, which may provide additional detail on growth drivers, margins, and customer momentum. Article Title

Institutional Trading of Arteris

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Needham Investment Management LLC increased its holdings in shares of Arteris by 2.6% during the 4th quarter. Needham Investment Management LLC now owns 3,411,500 shares of the company’s stock worth $52,878,000 after buying an additional 86,500 shares during the last quarter. Franklin Resources Inc. increased its holdings in shares of Arteris by 6.2% during the 4th quarter. Franklin Resources Inc. now owns 1,743,031 shares of the company’s stock worth $27,017,000 after buying an additional 101,646 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of Arteris by 8.2% during the 3rd quarter. Vanguard Group Inc. now owns 1,594,402 shares of the company’s stock worth $16,103,000 after buying an additional 120,947 shares during the last quarter. Westerly Capital Management LLC increased its holdings in shares of Arteris by 109.6% during the 3rd quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company’s stock worth $14,392,000 after buying an additional 745,000 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in Arteris by 144.7% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,012,670 shares of the company’s stock worth $15,696,000 after purchasing an additional 598,840 shares during the period. 64.36% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have weighed in on AIP shares. Rosenblatt Securities reiterated a “buy” rating and issued a $20.00 price target on shares of Arteris in a report on Friday, February 13th. Weiss Ratings restated a “sell (d-)” rating on shares of Arteris in a report on Monday, April 20th. Wall Street Zen downgraded Arteris from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Finally, Northland Securities set a $24.00 price objective on Arteris in a report on Friday, February 13th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Arteris has an average rating of “Hold” and a consensus price target of $20.17.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.